Indeed, some samples demonstrated an activated phosphorylation profile of IGF2R, further suggesting that some breast cancer samples might be targetable with precise segregation of RTKs with a suitable driver dependency nature14. The gene discussed is IGF2R; the disease is breast carcinoma.